富勒醇与血清白蛋白相互作用的光谱学研究
[1] Yin J J, Lao F, Meng J, et al. Mol. Pharmacol., 2008 , 74(4): 1132.
[2] Jiao F, Qu Y, Zhou G, et al. J. Nanosci. Nanotechnol., 2010, 10(12): 8632.
[3] Meng J, Liang X, Chen X, et al. Integr. Biol. (Camb), 2013, 5(1): 43.
[4] Song Y, Jin J, Li J, et al. J. Nanosci. Nanotechnol., 2014, 14(6): 4022.
[5] Kang S G, Zhou G, Yang P, et al. Proc. Natl. Acad. Sci. USA, 2012, 109(38): 15431.
[6] Gong J, Huo M R, Zhou J P, et al. International Journal of Pharmaceuties, 2009, 376(12): 161.
[7] Watanabe M, Kawano K, Toma K, et al. Journal of Controlled Release, 2008, 127(3): 231.
[8] HE Lian-qin, ZHU Liang(何练芹, 朱 亮). Chinese Pharmaceutical Journal(中国药学杂志), 2010, 45(2): 107.
[9] Yu X, Jiang B, Liao Z, et al. US National Library of Medicine National Institutes of Health, 2015, 149: 116.
[10] Chenq H, Zou T, Xu Y, et al. US National Library of Medicine National Institutes of Health, 2015, 10: 1002.
刘星, 沈鹏, 梁安文, 俞梅兰. 富勒醇与血清白蛋白相互作用的光谱学研究[J]. 光谱学与光谱分析, 2017, 37(11): 3530. LIU Xing, SHEN Peng, LIANG An-wen, YU Mei-lan. Study on Spectroscopy of Fullerols and Serum Albumin Interaction[J]. Spectroscopy and Spectral Analysis, 2017, 37(11): 3530.